City of Denver Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2003
NCT00140309
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Alternative names

C. Clay Cothren, MD | Denver Public Health | Rocky Mountain Poison and Drug Safety, division of Denver Health and Hospital Authority